학술논문
Discovery of mobocertinib, a potent, oral inhibitor of EGFR exon 20 insertion mutations in non–small cell lung cancer
Document Type
Article
Author
Huang, W.-S.; Li, F.; Gong, Y.; Zhang, Y.; Youngsaye, W.; Xu, Y.; Zhu, X.; Greenfield, M.T.; Kohlmann, A.; Taslimi, P.M.; Toms, A.; Zech, S.G.; Zhou, T.; Das, B.; Jang, H.G.; Tugnait, M.; Ye, Y.E.; Gonzalvez, F.; Baker, T.E.; Nadworny, S.; Ning, Y.; Wardwell, S.D.; Zhang, S.; Clackson, T.; Narasimhan, N.I.; Rivera, V.M.; Dalgarno, D.C.; Shakespeare, W.C.; Gould, A.E.; Hu, Y.; Skene, R.J.; Zou, H.; Lane, W.
Source
In: Bioorganic and Medicinal Chemistry Letters . (Bioorganic and Medicinal Chemistry Letters, 15 January 2023, 80)
Subject
Language
English
ISSN
14643405
0960894X
0960894X